Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies
News Releases - January 18, 2023
Dr. Larry Corey receives Alexander Fleming Award

Dr. Larry Corey receives Alexander Fleming Award

Virologist honored by peers for his lifetime achievements against infectious diseases
Community Compass - December 12, 2022
Antibody Mediated Prevention (AMP) Trials Data Published by the New England Journal of Medicine

Antibody Mediated Prevention (AMP) Trials Data Published by the New England Journal of Medicine

Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains
News Releases - March 17, 2021

News on HVTN

Read MORE
Year in Pictures: 2022 A look back at the year through compelling images December 12, 2022
Could a 100-year-old TB vaccine help scientists find a better one? Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis December 12, 2022
Dr. Larry Corey receives Alexander Fleming Award Virologist honored by peers for his lifetime achievements against infectious diseases October 21, 2022
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation NIAID director’s determined spirit recognized with honorary Hutch Award August 10, 2022